Prognostic value of cardiac 123I‐metaiodobenzylguanidine imaging for predicting cardiac events after transcatheter aortic valve replacement

• Main Authors: Yoshito Kadoya, Kan Zen, Nagara Tamaki, Masaki Yashige, Kazuaki Takamatsu, Nobuyasu Ito, Kensuke Kuwabara, Michiyo Yamano, Tetsuhiro Yamano, Takeshi Nakamura, Hitoshi Yaku, Satoaki Matoba
• Format: Article
• Language: English
• Published: Wiley 2021-04-01
• Series: ESC Heart Failure
• Subjects: Cardiac 123I‐metaiodobenzylguanidine imaging; Aortic valve stenosis; Transcatheter aortic valve replacement; Heart–mediastinum ratio; Outcomes
• Online Access: https://doi.org/10.1002/ehf2.13123

Abstract Aims In patients with aortic valve stenosis (AS), cardiac sympathetic nervous (CSN) dysfunction and its improvement after transcatheter aortic valve replacement (TAVR) have been reported. The prognostic impact of CSN function remains unclear. This study investigated the prognostic value of cardiac 123I‐metaiodobenzylguanidine (MIBG) imaging for predicting cardiac events after TAVR. Methods and results This single‐centre prospective observational study enrolled patients with AS between July 2017 and May 2019. MIBG scintigraphy was performed before and soon after TAVR to evaluate the late heart–mediastinum ratio (L‐H/M). Patients were classified into three pairs of groups based on the baseline and post‐TAVR L‐H/M (≥2.0 or <2.0) and on the presence of TAVR‐related improvement in L‐H/M. The study endpoint was the occurrence of major adverse cardiac events (MACE), defined as a composite of all‐cause death, non‐fatal myocardial infarction, and hospitalization due to heart failure. Among the 187 consecutive patients who underwent TAVR, 107 (27 men; median age: 86 years) were evaluated. Over a median follow‐up of 366 days, 15 (14.0%) patients had MACE. The incidence of MACE was significantly low in patients with L‐H/M improvement and/or high post‐TAVR L‐H/M (≥2.0). Baseline L‐H/M and frailty were associated with poor response of L‐H/M to TAVR treatment. TAVR‐related improvement in L‐H/M had significant effects on MACE, with an adjusted hazard ratio of 0.233 (95% confidence interval, 0.064–0.856; P = 0.028). Conclusions TAVR‐related improvement in L‐H/M was an independent predictor of cardiac events, 1 year after TAVR. Cardiac MIBG imaging is useful for predicting cardiac events after TAVR.